Alexander Nowak analyst CRAIG HALLUM

Currently out of the existing stock ratings of Alexander Nowak, 87 are a BUY (84.47%), 14 are a HOLD (13.59%), 2 are a SELL (1.94%).

Alexander Nowak

Work Performance Price Targets & Ratings Chart

Analyst Alexander Nowak, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 43.65% that have a potential upside of 52.86% achieved within 144 days.

Alexander Nowak’s has documented 226 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVRX, CVRx at 11-Jul-2024.

Wall Street Analyst Alexander Nowak

Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for CDNA (CAREDX) at 5/1/2024. The price target of $15 was fulfilled within 13 days with a profit of $5.82 (63.4%) receiving and performance score of 48.77.

Average potential price target upside

CDNA Caredx CELC Celcuity LLC EXAS EXACT Sciences INFU InfuSystems Holdings NEO NeoGenomics NTRA Natera QDEL Quidel SDC SmileDirectClub TECH Bio-Techne Corp TNDM Tandem Diabetes Care DRIO DarioHealth Corp HTGM HTG Molecular Diagnostics SIEN Sientra DMAC DiaMedica Therapeutics BVS Bioventus ALIM Alimera Sciences CVRX CVRx

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

16

$-2.09 (-11.55%)

14

9 days ago

3/7 (42.86%)

$-2.3 (-12.57%)

157

Hold

1 months 25 days ago

6/6 (100%)

$5.95 (12.13%)

165

Buy

12

2 months 13 days ago

3/11 (27.27%)

$2.34 (24.22%)

68

Buy

18

$-0.09 (-0.50%)

10

2 months 13 days ago

4/6 (66.67%)

$3.02 (20.16%)

48

Hold

15

$-3.09 (-17.08%)

9

2 months 25 days ago

9/14 (64.29%)

$5.82 (63.40%)

81

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Alexander Nowak is most bullish on?

Potential upside of $11.49 has been obtained for NEO (NEOGENOMICS)

Which stock is Alexander Nowak is most reserved on?

Potential downside of -$3.09 has been obtained for CDNA (CAREDX)

What Year was the first public recommendation made by Alexander Nowak?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?